333 related articles for article (PubMed ID: 33667514)
1. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis.
Liu C; Wang H; Tang L; Huang H; Xu M; Lin Y; Zhou L; Ho L; Lu J; Ai X
Life Sci; 2021 Jun; 275():119288. PubMed ID: 33667514
[TBL] [Abstract][Full Text] [Related]
2. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
[TBL] [Abstract][Full Text] [Related]
5. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
7. LINC01006 regulates the proliferation, migration and invasion of hepatocellular carcinoma cells through regulating miR-433-3p/CBX3 axis.
Song Y; Wang S; Cheng X
Ann Hepatol; 2021; 25():100343. PubMed ID: 33781916
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
Tang SJ; Yang JB
Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-363-3p/RNF38 axis.
Hu PA; Miao YY; Yu S; Guo N
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3592-3604. PubMed ID: 32329834
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
Zou Y; Sun Z; Sun S
J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00858 promotes cells proliferation and invasion through the miR-153-3p/Rabl3 axis in hepatocellular carcinoma.
Qi WY; Mao XB; He YB; Xiao CH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9343-9352. PubMed ID: 33015775
[TBL] [Abstract][Full Text] [Related]
18. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-HEIH suppresses hepatocellular carcinoma cell growth and metastasis by up-regulating miR-199a-3p.
Wu MM; Shen WD; Zou CW; Chen HJ; Guo HM
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6031-6038. PubMed ID: 32572917
[TBL] [Abstract][Full Text] [Related]
20. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
